Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Malignant neoplasm of breast
|
2154 | 0.605 | 0.440 | 3 | 179218294 | missense variant | G/A;C | snv | 0.730 | 1.000 | 3 | 2014 | 2019 | ||||||
Liver carcinoma
|
769 | 0.605 | 0.440 | 3 | 179218294 | missense variant | G/A;C | snv | 0.710 | 1.000 | 1 | 2008 | 2016 | ||||||
Seborrheic keratosis
|
10 | 0.605 | 0.440 | 3 | 179218294 | missense variant | G/A;C | snv | 0.710 | 1.000 | 1 | 2007 | 2007 | ||||||
Breast Carcinoma
|
2145 | 0.605 | 0.440 | 3 | 179218294 | missense variant | G/A;C | snv | 0.030 | 1.000 | 3 | 2014 | 2019 | ||||||
Neoplasms
|
1571 | 0.605 | 0.440 | 3 | 179218294 | missense variant | G/A;C | snv | 0.030 | 1.000 | 3 | 2009 | 2019 | ||||||
Adult Anaplastic Oligodendroglioma
|
4 | 0.605 | 0.440 | 3 | 179218294 | missense variant | G/A;C | snv | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||
Anaplastic Oligodendroglioma
|
6 | 0.605 | 0.440 | 3 | 179218294 | missense variant | G/A;C | snv | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||
Biliary Tract Cancer
|
11 | 0.605 | 0.440 | 3 | 179218294 | missense variant | G/A;C | snv | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||
Carcinoma
|
90 | 0.605 | 0.440 | 3 | 179218294 | missense variant | G/A;C | snv | 0.010 | 1.000 | 1 | 2008 | 2008 | ||||||
cervical cancer
|
257 | 0.605 | 0.440 | 3 | 179218294 | missense variant | G/A;C | snv | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
Cervix carcinoma
|
266 | 0.605 | 0.440 | 3 | 179218294 | missense variant | G/A;C | snv | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
Childhood Anaplastic Oligodendroglioma
|
4 | 0.605 | 0.440 | 3 | 179218294 | missense variant | G/A;C | snv | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||
Colon Carcinoma
|
275 | 0.605 | 0.440 | 3 | 179218294 | missense variant | G/A;C | snv | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
HER2-negative breast cancer
|
18 | 0.605 | 0.440 | 3 | 179218294 | missense variant | G/A;C | snv | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||
HER2-positive carcinoma of breast
|
26 | 0.605 | 0.440 | 3 | 179218294 | missense variant | G/A;C | snv | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||
Malignant tumor of cervix
|
245 | 0.605 | 0.440 | 3 | 179218294 | missense variant | G/A;C | snv | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
Malignant tumor of colon
|
289 | 0.605 | 0.440 | 3 | 179218294 | missense variant | G/A;C | snv | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
Mixed Salivary Gland Tumor
|
3 | 0.605 | 0.440 | 3 | 179218294 | missense variant | G/A;C | snv | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||
Papilloma
|
25 | 0.605 | 0.440 | 3 | 179218294 | missense variant | G/A;C | snv | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
Salivary duct carcinoma
|
9 | 0.605 | 0.440 | 3 | 179218294 | missense variant | G/A;C | snv | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||
Squamous cell carcinoma
|
197 | 0.605 | 0.440 | 3 | 179218294 | missense variant | G/A;C | snv | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||
Undifferentiated (Embryonal) Sarcoma
|
4 | 0.605 | 0.440 | 3 | 179218294 | missense variant | G/A;C | snv | 0.010 | 1.000 | 1 | 2014 | 2014 |